The midterm elections of 1994 brought on political change that cost Dingell chairmanship of Energy & Commerce and Oversight and Investigations. He lost most of his staff, and there was no reason to continue oversight hearings of NSABP.
On a single day in March, Dr. Bernard Fisher of Pittsburgh, the country's pre-eminent breast cancer researcher, saw his own career crumble, and watched helplessly as the research organization he had led through unprecedented advances in the treatment of breast cancer was abruptly shut down.
Bernard Fisher had been in many a fight. He was, after all, an iconoclastic surgeon who had famously infuriated his colleagues by demonstrating that heroic surgeries in breast cancer do more harm than good.
Bernard Fisher, a surgeon and clinical trialist who revolutionized the field of breast cancer research and all but eliminated reliance on disfiguring surgeries, died Oct. 16 at the age of 101.
The Dutch company Xenikos B.V. said FDA has granted Fast Track designation to T-Guard, Xenikos's product designed to treat steroid-refractory acute graft-versus-host disease in patients following allogeneic stem cell transplantation.
Flatiron Health announced the availability of its clinical decision support and pathways application, Flatiron Assist, in the App Orchard.
The UCLA Jonsson Comprehensine Cancer Center has launched a CAR T-cell immunotherapy trial that will attack cancer cells by simultaneously recognizing two targets—CD19 and CD20—that are expressed on B-cell lymphoma and leukemia.
Novocure said the results from the STELLAR trial were published in The Lancet Oncology.
The International Association for the Study of Lung Cancer announced an open comment period for the “IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens Following Neoadjuvant Therapy” paper.
Getting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist's visual assessment of biopsy material on microscopic slides, which can often be subjective.
